Form 4 for MED MEDIFAST INC
Accepted 2022-06-21 00:00:00 ET · period of report 2022-06-16 · accession 0001104659-22-073168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-21 | 2022-06-16 | MED | HALLQUIST CONSTANCE J. | Dir | A - Grant | $0.00 | +1,432 | 7,874 | +22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-16 | A | A | 1,432 | $0.00 | 7,874 | D | — | — | (F1) Represents the right to receive 1,432 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023. |